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Abstract
Background: Respiratory disease is a common cause for presentation of working 
horses to clinics in Ethiopia and a priority concern for owners.
Objectives: To identify risk factors for and association of pathogens with respiratory 
signs in working horses.
Study design: Unmatched case-control study.
Methods: Cases were those animals recently coughing (last 7 days) or observed with 
coughing, nasal discharge or altered respiration at the time of examination. A physical 
exam and respiratory endoscopy were performed including a tracheal wash sample 
to detect the presence of pathogens and serology performed on blood. An owner 
questionnaire was administered. Risk factors were determined using multivariable 
logistic regression.
Results: Data on 108 cases and 93 unmatched control horses were obtained. Case 
horses often had underlying lower airway pathology and were significantly more 
likely to have Streptococcus zooepidemicus detected (OR: 12.4, 95% CI: 3.6-42.4). 
There was no evidence of a major role for viral respiratory pathogens. Risk factors 
included completion of strenuous work (OR: 2.7, 95% CI: 1.2-6.3), drinking from stag-
nant water sources (OR: 2.3, 95% CI: 1.0-5.2) or being housed on a cobbled floor (OR: 
2.0, 95% CI: 1.1-3.8). There were increased odds of respiratory disease in young and 
old horses in this population.
Main limitations: Samples for pathogen detection and cytology were only taken from 
the trachea.
Conclusion: S. zooepidemicus, a common commensal, may play a role in clinical res-
piratory disease in this population.
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1  | INTRODUC TION
Respiratory disease is a major cause of time off work and poor per-
formance for equids. In Ethiopian working horses, coughing and 
nasal discharge are frequently identified at clinics (SPANA clinic 
data, unpublished). They are a priority health concern for owners1 
and are often 'poorly defined’.2 Limited diagnostic options mean a 
presumptive diagnosis is typically based on clinical history and ex-
amination alone.
Serological surveys from this study area suggested a role for 
Streptococcus equi subspecies equi (S. equi)3 and alphaherpesviruses 
(equine herpes virus (EHV) 1/4)).4,5 Endemicity of these pathogens 
occurs in other equine populations and causality in respiratory dis-
ease is well established.6,7 There was no serological evidence of 
equine influenza virus (EIV) in a previous study,3 but given its global 
prevalence and potential impact in a naïve population, its presence 
was further examined here. Additionally, the picornaviruses, equine 
rhinitis virus A (ERAV) and B (ERBV), were recognised as frequent 
contributors to respiratory disease,8,9 and the role of lesser charac-
terised pathogens of the equine airways was considered in this study 
given the limited data on respiratory disease in sub-Saharan Africa 
equines. The gammaherpesviruses EHV-2 and -5 are ubiquitous in 
equine respiratory secretions, but evidence for their causal role in 
disease is conflicting.10,11 Streptococcus zooepidemicus, commonly 
considered a commensal, has also been frequently linked with clini-
cal signs and outbreaks of respiratory disease12,13 and was therefore 
investigated here.
Noninfectious respiratory disease includes a spectrum of asthma 
often presenting with coughing, exercise intolerance and nasal 
discharge. Severe equine asthma (previously recurrent airway ob-
struction, RAO) is widely recognised and is likely a hypersensitivity 
response to inhaled organic dusts where, in contrast to milder forms 
of equine asthma, an increased respiratory effort is apparent at rest. 
Mild forms of equine asthma (previously inflammatory airway dis-
ease, IAD) tend to affect younger horses. Presentation may be sub-
clinical with a variable inflammatory profile in airways.14
This case-control study aimed to investigate the underlying pa-
thology in airways of horses with overt clinical signs; identify any 
horse- or management-level factors that may increase the odds of 
disease; and determine associations between infectious agents and 
respiratory signs using molecular detection of organisms in lower 
airways and serological evidence for exposure to known pathogens 
of the equine respiratory tract. This work will aid the therapeutic 
decisions taken by veterinarians in Ethiopia, and the advice provided 
for prevention of disease in working equids.
2  | MATERIAL S AND METHODS
Case and control horses were identified at four SPANA clinic loca-
tions (two static and two mobile) in Oromia region, Ethiopia, be-
tween September and December 2014. Horses reported with recent 
coughing (last 7 days) or observed coughing, with nasal discharge 
or altered respiration (rate and/or character) at examination were 
defined as cases. Controls were unmatched and systematically se-
lected as the next horse presenting without a history or signs of 
respiratory disease that did not require immediate attention on 
welfare grounds. Horses with suspected African Horse Sickness, 
Epizootic Lymphangitis, Glanders, severe pleuropneumonia and 
where epistaxis was the only sign were excluded from the study. A 
sample size of 94 cases and 94 unmatched controls was estimated15 
to detect an odds ratio of 2.5 or greater with exposures of 20% or 
more, with 80% power and 95% confidence intervals. Participants 
were fully informed and gave verbal consent for inclusion in the 
study and were present throughout the procedure which they could 
ask to be stopped at any time. Owners also completed an individual 
verbal questionnaire (Data S1) in either Amharic or Afan Oromo (TA).
Clinical examination and endoscopy of the respiratory tract (to 
the carina) were performed by a single veterinarian (G.L.). Due to the 
requirement for horses to work after examination, sedative agents 
were not administered but a humane nose twitch was applied for a 
maximum 20 minutes limiting examination to a single naris insertion 
route, single sample collection point and brief inspection of URT. Full 
ethical approval was granted with abandonment of examination if 
animals showed any signs of distress. Secretions at the ‘sump’ of the 
trachea were sampled by flushing 20 mL of sterile phosphate-buff-
ered saline (ambient temperature), via a sterile endoscopic catheter. 
The endoscope underwent a full cleaning routine between animals 
with biological detergent followed by 20-minute submersion in glu-
taraldehyde disinfectant.
Fixed slides of tracheal wash sediment were imported to the 
UK (TARP/2014/163), stained with May-Grunwald-Giemsa and 
evaluated by a single board-certified clinical pathologist (F.C.) using 
methods adapted from Whitwell and Greet (1984).16 This included 
leucocyte differential count (minimum 200 cells, excluding epithe-
lials) and subjective evaluation of mucus, epithelial cells and infec-
tious agents.
Nucleic acid extraction was performed manually on 200 µL of 
tracheal wash sediment within 4 hours of collection using a commer-
cial kit (Pure Viral RNA Kit, Roche Diagnostics). Samples were stored 
at −20°C. Freezer storage at −80°C (recommended for RNA) was not 
available. Therefore, to stabilise RNA samples, 10 µL of extracted 
nucleic acids was applied to Whatman FTA cards (GE Life sciences)17 
and stored at −20°C until transportation to UK and then stored at 
−80°C (IMP/GEN/2008/03). Nucleic acids were eluted from FTA 
cards using methods adapted from Chomczynski18 and used for de-
tection of RNA viruses: EIV, ERAV/ERBV and equine arteritis virus 
(EAV). Diagnostic tests are described in Table 1 and Table S1.
2.1 | Data analysis
Associations between clinical, endoscopic and cytological variables 
and case-control status were assessed using univariable logistic 
regression analyses. Secondly, horse-, owner- and management-
level factors were investigated for associations with case-control 
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status using univariable then multivariable logistic regression mod-
els. Continuous variables were assessed for linearity using gen-
eralised additive models (GAMs). All variables with P < .25 were 
assessed for correlation before inclusion in a multivariable model. 
A manual backwards stepwise approach eliminated each variable 
until only those with a likelihood ratio P < .05 remained, or where 
their removal resulted in a >25% change in coefficient of another 
variable. The final model was assessed for two-way interactions, 
TA B L E  1   Diagnostic tests used for detection of multiple pathogens from equine respiratory secretions
Pathogen PCR test Details Methods Primers
Equine influenza virus Real time RT-qPCR Multiplex NP & M 33 NP F TTCTGGAGAGGTGAAAATGG
NP R CATAAACACAGGCAGGTAGG
M F ACCGAGGTCGAAACGTACGT
M R CGCGATCTCGGCTTTGA
Equine arteritis virus Real time RT-qPCR 34 F GGCGACAGCCTACAAGCTACA
R CGGCATCTGCAGTGAGTGA
Equine rhinitis virus A/B Real time RT-qPCR Multiplex AHT ERAV target: 5'UTR region
ERBV target: 3D Pol region
Equine herpesvirus 1/4 Real time qPCR Multiplex AHT EHV-1 gB gene
EHV-4 gC gene
Equine herpesvirus 2 Semi-nested PCR Round 1 24 F ATGCTCTCTGACAAGAATCACTAC
R TGTTGTAGACAATGGGAATCTG
Nested round 2 R2 CGAGACAAACATCTTTTTCTCT
Equine herpesvirus 5 Nested PCR Round 1 Liverpool Uni. F ATGAACCTGACAGATGTGCC
R CACGTTCACTATCACGTCGC
Nested round 2 F GATTTCCAGGTGATACAGCTC
R ATCGTGGATGGAGTCATCCAG
S. equi Real time qPCR Multiplex 35 eqbE2 F TGGGATTCTGTGCCGATTTT
ex. SZIC 
control
eqbE2 R CAACGCGTAGAAGAACGATCTAAA
2,190 F CAACGCGTAGAAGAACGATCTAAA
2,190 R CCTCCAATTGAGCTTTTTGGTT
SZIC F CGCATGCGGGTAGATTATGTAG
SZIC R TCCCACGAGAAGGTCGAGAA
S. zooepidemicus Real time PCR Multiplex, E. coli IPC AHT Target gene: 8,800
Target gene: 8,940
B. bronchiseptica PCR assay Subset 20 cases 36 F CCCCCGCACATTTCCGAACTTC
Multiplex R AGGCTCCCAAGAGAAAGGCTT
F CACCTGCCCCATCTCC
R TGGCGCCTGCCCTATC
M. felis PCR assay Case samples only 37 F CTTGCGACCTAACAAGTCC
R GGACTATTATCAAAAGCACATAAC
Serology test
Sensitivity/
specificity Criteria for positive cut-off
S. equi Dual Antigen A & C 
ELISA
93.3%/99.3% 20 Positive: OD ≥ 0.5
Borderline: OD = 0.3-0.4
Equine arteritis virus ELISA, Virus 
Neutralisation
96.8%/95.6% 38,39 OD change ≥0.5
Neutralisation ≥75%
Equine herpesvirus (1/4) Complement fixation 22 Reciprocal dilution titre ≥1:80
Equine rhinitis virus (A/B) Complement fixation 22 Reciprocal dilution titre ≥1:80
Equine influenza virus ELISA, Haemagglutinin 
inhibition
95.3%/79%-99% 40,41 Percentage inhibition ≥55%
Reciprocal dilution titre ≥1:32
Abbreviations: qPCr, quantitative PCR; RT, reverse transcription; IPC, internal PCR control; OD, optical density; ELISA, enzyme-linked 
immunosorbent assay; OIE, World Org. for Animal Health; AHT, Animal Health Trust.
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and Hosmer-Lemeshow statistic was used for goodness of fit. Delta-
beta values and influence plots were used to identify the sensitivity 
of the model to individual observations. Finally, pathogen associa-
tions with case-control status were also investigated using logistic 
regression but adjusted for age as a potential confounder as this 
demonstrated a biologically plausible and statistically significant as-
sociation and may also be associated with pathogen exposure. All 
analysis was performed using R (version 3.1.2, R Foundation for 
Statistical Computing).
3  | RESULTS
Clinical examination and tracheal endoscopy were performed on 
108 cases and 93 unmatched controls with nine of those invited to 
participate declining (this initial communication was done in the local 
language hence, exact reasons for declining were not recorded) and 
nine examinations were abandoned for behavioural reasons. Cases 
presented with one or more signs including: coughing (89% histori-
cal and 36% during examination), 54% nasal discharge (48% serous, 
52% mucoid or mucopurulent) and one epistaxis episode. A fifth 
(19%) of cases also showed altered respiratory signs. The majority 
of cases (87%) were being examined for the first time and partici-
pants reported reduced work ability in 54%. The majority of controls 
presented for preventive treatments or administrative documenta-
tion (75%) and lameness (23%). All animals examined were male and 
breed type did not vary across sample sites. Nearly all cases (96%) 
and controls (99%) were used as cart horses and presented by the 
owner (98%).
Univariable analyses of clinical and endoscopic findings are 
presented in Tables 2 and 3 and Figures S1 and S2. Case horses 
were significantly more likely to have abnormal lung sounds, in-
creased tracheal mucus and increased neutrophil count and de-
creased lymphocyte proportions in tracheal wash cytology (with 
reference to the most widely accepted limits for normal). In addi-
tion, case horses were more likely to have intracellular bacteria in 
respiratory secretions. Both cases (29%) and controls (39%) fre-
quently showed increased respiratory eosinophils but there was 
no significant difference in cases or controls.
Univariable analysis results of horse, owner and management 
variables are presented in Table S2 and S3 and the final multivari-
able model is shown in Table 4. The association of cases with clinic 
location or date examined was initially assessed as a fixed effect 
in a univariable logistic regression model but neither proved sig-
nificant. Age of horse was significant (P = .02) and a GAM for esti-
mated age demonstrated a nonlinear relationship with case status 
(Figure 1); a quadratic polynomial provided the best fit, suggest-
ing young horses and older horses were at increased risk, with the 
lowest risk for horses 9-10 years. Exercise intensity was signifi-
cantly associated with respiratory cases, with horses performing 
strenuous exercise at nearly three times greater risk. The effect 
was independent of number of hours worked. Cases were also 
more likely to have recently drank from a stagnant water source 
and be housed on a cobbled floor when compared with bare earth 
or concrete floors. No participants reported using bedding. The 
housing floor type was retained in the final model despite the 
likelihood ratio test statistic of 0.06, as its inclusion improved the 
overall model fit as assessed by the Hosmer-Lemeshow test (there 
was significant evidence of poor fit if floor type was excluded 
[Table 4]). Furthermore, floor type was significant (LRS P = .04) 
in the model excluding exercise intensity where there were fewer 
missing values. There were no significant two-way interactions 
identified in the final model.
Age-adjusted logistic regression models of associations between 
pathogens and respiratory cases are presented in Table 5. All sam-
ples tested were negative for EIV, EAV, EHV-1, Mycoplasma felis and 
Bordetella bronchiseptica. One young case (1-2 years), presenting 
with serous nasal discharge and pyrexia, was PCR positive for EHV-
4. A single case with a historical cough and enlarged submandibular 
lymph nodes was tested PCR positive for ERAV. A further two cases 
and two controls were tested positive for ERBV with cases having 
co-infections with EHV-2 and/or EHV-5 and S. zooepidemicus. EHV-2 
and -5 were the most frequently encountered pathogens in both 
cases (55%, 51%) and controls (58%, 55%) but neither were signifi-
cantly associated with case status.
Seropositive status to S. equi was found in 19% of cases and 
11% of control animals. There were also four cases and one control 
with S. equi organisms detected in respiratory secretions by PCR. 
TA B L E  2   Univariable logistic regression results of cardiorespiratory and haematological continuous variables from physical exam 
associated with respiratory cases in working horses in Ethiopia (n = 201, 108 cases and 93 controls)
Variable
Median 
case IQR
Median 
control IQR
Odds 
ratio
Lower 
95% CI
Upper 
95% CI
Wald 
P-value
Respiratory rate (br/m) 32 20-44 28 20-40 1.02 1.00 1.04 .08
Heart rate (bpm) 48 44-52 44 40-52 1.02 0.98 1.06 .4
Packed cell volumea  30% 28%-33% 32% 30%-34% 0.02 0.00 12.40 .22
Total plasma proteina   
(g/dL)
7.6 7.3-8.0 7.6 7.2-8.0 0.90 0.70 1.20 .5
Note: Due to apparent discordance between the Ethiopian results and published reference intervals, the lack of obvious cut-offs for normal and to 
avoid loss of data, cardiorespiratory and haematological parameters were analysed as continuous variables.
Abbreviations: IQR, inter-quartile range; CI, confidence interval.
aPacked cell volume (PCV) and total plasma protein (TPP) were measured manually. 
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TA B L E  3   Univariable logistic regression results of physical examination, endoscopic and cytological findings associated with respiratory 
cases in working horses in Ethiopia (n = 201, 108 cases and 93 controls)
Variable
Case Control
Odds ratio Lower 95% CI Upper 95% CI Wald P-valuen (%) n (%)
Clinical exam findings
Cranial lymph nodes
Normal 104 (96) 93 (100) ref
Enlarged 4 (4) 0 (0) 3.5 0.4 32.2 .2
Respiratory auscultation
Normal 53 (50) 84 (90) ref
Abnormal 54 (50) 9 (10) 9.5 4.3 20.8 <.01
Pyrexia
<39.0°C 98 (93) 89 (99) ref
≥39.0°C 7 (7) 1 (1) 6.4 0.8 52.7 .09
Demeanour
Bright & responsive 84 (78) 72 (77) ref
Quiet or dull 24 (22) 21 (23) 1.0 0.5 2.0 .5
Blood parameters
Packed cell volume
<30% 34 (31) 21 (23) 1.6 0.8 3.0 .2
30%-46% 74 (69) 72 (77) ref
>46% 0 (0) 0 (0) —
Total plasma protein
<6.5 g/L 0 (0) 2 (2) 0.7 0.1 7.5 .7
6.5-7.3 g/L 28 (26) 35 (38) ref
>7.3 g/L 79 (74) 56 (60) 1.8 1.0 3.4 .05
Neutrophil proportion
<45% 10 (9) 12 (13) 0.6 0.2 1.7 .3
45%-55% 22 (21) 15 (16) ref
>55% 75 (70) 66 (71) 0.8 0.4 1.6 .50
Eosinophil proportion
≤5% 94 (88) 84 (90) ref
>5% 13 (12) 9 (10) 1.3 0.5 3.2 .6
Lymphocyte proportion
<35% 77 (72) 65 (70) 1.0 0.5 1.9 .90
35%-50% 26 (24) 21 (23) ref
>50% 4 (4) 7 (8) 0.5 0.1 1.8 .3
Monocyte proportion
≤3% 27 (25) 23 (25) ref
>3% 80 (75) 70 (75) 1.0 0.5 1.9 .9
Endoscopy findings
Cough on endoscopy
None or occasional 37 (36) 81 (87) ref
Frequent or severe 65 (64) 12 (13) 11.9 5.7 24.6 <.01
Lymphoid hyperplasia
Grade 0-2 101 (99) 93 (100) —
Grade 3-4 1 (1) 0 (0) —
(Continues)
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Variable
Case Control
Odds ratio Lower 95% CI Upper 95% CI Wald P-valuen (%) n (%)
Tracheal mucus
Grade 0-1/3 65 (64) 92 (99) ref
Increased (≥2/3) 36 (36) 1 (1) 51.0 6.8 381.1 <.01
Carina appearance
Normal 90 (90) 82 (89) ref
Blunted carina 10 (10) 10 (11) 0.9 0.4 2.3 .8
Blood in wash sample
Not identified 89 (88) 83 (90) ref
Blood present 12 (12) 9 (10) 1.2 0.5 3.1 .6
Tracheal wash cytologya 
Neutrophil proportionb 
≤19% 24 (23) 47 (54) ref
>19% 81 (77) 40 (46) 4.0 2.1 7.4 <.01
Lymphocyte proportion
≤21% 100 (95) 72 (83) ref
>21% 5 (5) 15 (17) 0.1 0.1 0.3 <.01
Monocyte proportion
≤96% 105 (100) 87 (100)
>96% 0 (0) 0 (0)
Eosinophil proportion
≤2% 77 (73) 53 (61) ref
>2% 28 (27) 34 (39) 0.6 0.3 1.0 .07
Mast cell proportion
0% 99 (94) 84 (97) ref
>0% 6 (6) 3 (3) 1.7 0.4 7.0 .5
Intracellular bacteriac 
Not identified 87 (83) 86 (99) ref
Present 18 (17) 1 (1) 18.6 2.4 142.3 <.01
Degenerative neutrophils
Not identified 102 (95) 92 (99) ref
Present 5 (5) 1 (1) 4.5 0.5 39.3 .2
Squamous epithelial cells
Not identified 89 (83) 59 (63) ref
Present 18 (17) 34 (37) 0.4 0.2 0.7 <.01
RBC on smeard 
Not identified 97 (92) 82 (94) ref
Present 8 (8) 5 (6) 1.4 0.4 4.3 .6
Note: Clinical, endoscopic and cytological variables are all likely to be effects of, rather than causes of, underlying respiratory disease and as such 
were not assessed as potential risk factors in multivariable regression. Missing observations for some aspects of examination due to recording errors 
or missing data due to horse temperament. Eight tracheal wash samples had insufficient cells to perform a differential cell count. 
Abbreviation: CI, confidence interval. ref, reference catgeory 
aThere are no published accepted reference intervals for tracheal wash differential cell counts, so values used in this study were those of  
Richard et al,42 who considered a range of studies to establish cut-offs. 
bStrong neutrophilic inflammation can make it difficult to assess other cell lines accurately. 
c67% of cases where intracellular bacteria morphology was described (8/12) were cocci. 
dHaemosiderophage, an indicator of previous bleeding in the lungs, was a rare finding and was noted in just one control horse. 
TA B L E  3   (Continued)
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However, neither were significantly associated with respiratory 
signs in this study.
Horses with S. zooepidemicus detected in tracheal wash sam-
ples were more likely to present as a case of respiratory disease 
(OR: 12.4, CI 3.6-42.4). S. zooepidemicus was found in combination 
with other pathogens in several cases: EHV-4 (n = 1), EHV-2 or −5 
(n = 20) and in horses seropositive for S. equi (n = 8), but was found 
in isolation in two cases. All three control animals positive for S. 
zooepidemicus, compared with just two of 31 case horses, had squa-
mous epithelial cells identified on cytology suggesting that samples 
may be infrequently contaminated from the upper respiratory tract 
(URT). Fourteen cases also had intracellular bacteria in lower respi-
ratory tract (LRT) macrophages. Fourteen cases had no infectious 
agents detected either on serology or PCR. Of those, only two had 
a normal tracheal cytology profile. Further information on all case 
presentations are in Data S2.
4  | DISCUSSION
This is the first study to examine the association between infec-
tious agents and signs of respiratory disease in working horses of 
Ethiopia. There was a significant association of S. zooepidemicus with 
respiratory cases in our study. Although S. zooepidemicus is consid-
ered a commensal of the URT, and the method of sampling in this 
study could be vulnerable to contamination from the URT, the pres-
ence of intracellular bacteria on tracheal smears supports a true 
septic inflammation in the LRT rather than a transient colonisation. 
Furthermore, any URT contamination due to sampling methodology 
would affect cases and controls equally.
Streptococcus zooepidemicus in the LRT has been implicated as a 
primary pathogen in respiratory disease12 and linked to equine asthma 
(mild) and subclinical respiratory disease.19 A role in subclinical dis-
ease was not identified in this study, however, with very few control 
horses testing positive. It is unclear whether its role was as a primary 
pathogen or as a secondary opportunistic infection of the lower air-
ways. This is of interest in this study due to the frequent occurrence of 
co-infections with other respiratory pathogens. Previously, different 
strains of S. zooepidemicus have been linked with different pathogenic 
TA B L E  4   Multivariable logistic regression model of factors associated with respiratory cases in working horses in Ethiopia (n = 190, 102 
cases and 88 controls)
Variable Coefficient (Std. error) Odds ratio Lower 95% CI Upper 95% CI LRS P-value
Age centred (y) 0.03 (0.03) 1.03 0.97 1.09 .3
Age centred squared (y) 0.01 (0.01) 1.01 1.00 1.02 .03
Work intensity
Easy-moderate or variable ref .02
Strenuous 0.99 (0.43) 2.69 1.15 6.31
Drank stagnant water (last 14 d)
No ref .05
Yes 0.82 (0.42) 2.27 1.00 5.20
Floor type (housing)
Bare earth/sandy soil ref .06a 
Flat rocks (cobbled) 0.69 (0.33) 1.99 1.05 3.81
Concrete −0.31 (0.56) 0.74 0.24 2.23
Abbreviations: CI, confidence interval; LRS, likelihood ratio statistic.
aThis variable was retained in the model as it improved the overall model fit (as assessed by Hosmer-Lemeshow test). The Hosmer-Lemeshow statistic 
for model fit did not indicate the model fit was poor (P = .4) when floor type was included but indicated significant evidence of poor fit if floor type 
was excluded (P = .01). Furthermore, floor type was significant (P = .04) in the model excluding exercise intensity where there were fewer missing 
values. Influence and delta-beta plots identified clusters of two and three samples with the highest leverage on the model. Leverage was less than 
0.15 for all individuals and the influence exerted to perturb the model was low. 
F I G U R E  1   Generalised additive model (GAM) plot to show 
the nonlinear relationship between horse dental age (estimated in 
years) and case-control status for respiratory disease
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TA B L E  5   Age-adjusted logistic regression results of serology and PCR results for pathogens associated with respiratory cases in working 
horses in Ethiopia, adjusted for age as a quadratic term (n = 201, 108 cases and 93 controls)
Variable
Case Control
Odds 
ratio Lower 95% CI Upper 95% CI Wald P-valuen (%) n (%)
Viral pathogens
Eq. herpesvirus-1
PCR− 108 (100) 93 (100)
PCR+ 0 (0) 0 (0)
Serostatus
CF- 108 (100) 92 (100)
CF+ 0 (0) 0 (0)
Eq. herpesvirus-4
PCR− 107 (99) 93 (100)
PCR+ 1 (1) 0 (0)
Serostatus
CF- 108 (100) 92 (100)
CF+ 0 (0) 0 (0)
Eq. herpesvirus-2
PCR− 49 (45) 46 (49)
PCR+ 59 (55) 47 (51) 1.03 0.59 1.82 .9
Eq. herpesvirus-5
PCR− 45 (42) 42 (45)
PCR+ 63 (58) 51 (55) 0.84 0.48 1.49 .6
Eq. arteritis virus
PCR− 108 (100) 93 (100)
PCR+ 0 (0) 0 (0)
Eq. influenza virus
PCR−− 108 (100) 93 (100)
PCR+ 0 (0) 0 (0)
Eq. rhinitis virus-A
PCR− 107 (99) 93 (100)
PCR+ 1 (1) 0 (0)
Serostatus
CF- 108 (100) 92 (100)
CF+ 0 (0) 0 (0)
Eq. rhinitis virus-B
PCR− 106 (98) 91 (98)
PCR+ 2 (2) 2 (2) 0.82 0.11 6.09 .9
Serostatus
CF- 108 (100) 92 (100)
CF+ 0 (0) 0 (0)
Bacterial pathogens
S. equi
PCR− 104 (96) 92 (99)
PCR+ 4 (4) 1 (1) 3.36 0.36 31.10 .3
(Continues)
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attributes.13 It is unlikely that immunity to one strain type is cross-pro-
tective to infection with others, and therefore future work should 
quantify S. zooepidemicus in the LRT and examine strain types.
Serostatus for S. equi, the causative agent of strangles, was not 
significantly associated with signs of respiratory disease (P = .09); 
however, 11% of controls and nearly a fifth of case horses were 
seropositive, hence this may be due to low power to detect an as-
sociation. The persistence of raised antibody titres following res-
olution of clinical signs could also affect the level of association 
between serostatus and clinical signs.20 Similarly, chronic carriers 
of S. equi may shed bacteria and/or be seropositive for S. equi with-
out displaying clinical signs. A previous study in working equids in 
Lesotho also failed to demonstrate a significant association with 
clinical respiratory disease6 despite an overall prevalence of 10.1%, 
similar to the estimated prevalence of 8% found in this population 
in a previous cross-sectional study of 350 horses.3 Low rates of 
detection of S. equi in lower airways, despite many seropositive 
horses, may be a result of the suboptimal sampling site (S. equi is 
predominantly a URT pathogen found in the nasopharynx or gut-
tural pouches). Alternatively, clearance of the organism after infec-
tion could also lead to comparatively low PCR positives compared 
with serology findings. The small number of cases and resulting 
low power may also explain the lack of association between cur-
rent S. equi infection and clinical signs. Infection may be of greater 
importance in particular groups such as young naïve horses.
The overall low rates of detection for viral pathogens are in 
agreement with a previous seroprevalence study in this population,3 
which found no evidence of EIV and limited evidence of exposure of 
ERA/BV, EAV and EHV-1/-4. Low prevalence of viral pathogens is 
in contrast to studies in the United States, for example, where they 
are commonly detected,7 but the failure to find significant associa-
tions between viral pathogens and respiratory disease is consistent 
with another case-control study in the UK.21 The tracheal sampling 
site could contribute to low detection rates as it may not be ideal for 
URT pathogens, such as ERBV or EHV-1/4, but financial and logisti-
cal constraints meant a second sample site was not feasible in this 
study. As reported in a previous study,3 there was little evidence of 
EHV-1 and -4 in cases or controls, in contrast to Endebu-Duguma 
and Getachew et al,4,5 who suggested exposure to herpesviruses in 
Ethiopian horses is common. This likely represents a difference in 
diagnostic approach as previous studies measured virus-neutralis-
ing antibodies which can persist for up to a year in contrast to mea-
surement of viral nucleic acids in airways or complement fixating 
antibodies that last less than 3 months.22
ERBV was detected in equal numbers of cases and controls, and 
in cases it was only found as a co-infection with other respiratory 
pathogens. There is conflicting evidence for the role of ERBV in re-
spiratory disease,23 and a limitation of PCR testing is that it cannot 
discriminate a viable from a nonviable organism. Therefore, viral iso-
lation alongside PCR would have been desirable but was not feasible 
with current facilities in the field. ERAV was found in isolation in one 
case horse. This was the first study to look at the presence of gam-
maherpesviruses (EHV-2/5) in this population; although frequency 
of occurrence was high, there was no significant association with 
cases of respiratory disease, in agreement with other studies.24
A number of cases with lower airway inflammation had no de-
tectable infectious agent, supporting either a role for noninfectious 
aetiologies, infection with a novel pathogen or a failure to detect 
pathogens due to imperfect test sensitivity. This could also indicate 
an asthma-like chronic inflammatory disease known to be common 
in other equine populations.25
This study confirmed underlying airway pathology in Ethiopian 
horses presenting with respiratory signs such as increased tracheal 
mucus and tracheal neutrophilia. Lower airway inflammation leads 
Variable
Case Control
Odds 
ratio Lower 95% CI Upper 95% CI Wald P-valuen (%) n (%)
S. equi Serostatus
ELISA- 87 (81) 82 (89)
ELISA+ 21 (19) 10 (11) 2.02 0.89 4.60 .09
S. zooepidemicusa 
PCR− 73 (70) 89 (97)
PCR+ 31 (30) 3 (3) 12.39 3.62 42.42 <.01
Bordetella bronchiseptica
PCR− 20 (100) — (—)
PCR+ 0 (0) — (—)
Mycoplasma felis
PCR− 108 (100) — (—)
PCR+ 0 (0) — (—)
Abbreviations: CF, complement fixation; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction; CI, confidence interval.
aAnimals testing positive for S. equi on PCR were excluded from analysis due to cross-reaction, and results of S. zooepidemicus are limited to presence 
or absence information. 
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to increased mucus secretion that may subsequently lead to cough-
ing. Of those animals with increased tracheal mucus, over half were 
seen coughing during examination and the remainder all had a recent 
history of coughing in the last week. These results are in agreement 
with other studies that coughing is a specific indicator for tracheal 
mucus25 and further supports the potential usefulness of owner re-
porting in this population.26
Neutrophilia in respiratory secretions is a common occurrence 
in equine asthma, found in both mild and severe phenotypes, but 
also occurs in septic inflammation due to primary or secondary 
bacterial colonisation.21 Colonisation can occur with impairment 
of the mucociliary clearance seen in equine asthma, or following 
viral insult. Septic inflammation usually presents with a high per-
centage of neutrophils, a frequent finding in this study, and cases 
showed significantly more intracellular bacteria in secretions but 
the presence of degenerative cells, usually found with septic in-
flammation, was rare.
Nevertheless, 20% of cases had neither increased tracheal mucus 
nor neutrophilia, suggesting that respiratory disease may involve 
other pathologies, or that some animals were incorrectly classified 
as cases. Furthermore, an absence of clinically apparent signs did 
not rule out airway inflammation,19 and some control horses were 
found to have abnormal cytology results, inclusion of which could 
bias results towards the null if misclassified.
Eosinophilia was a frequent finding in cases but also in controls 
and was not associated with presentation for respiratory disease, as 
found in other studies. This may suggest subclinical airway disease 
or severe asthma during remission.27 Eosinophilia may also be asso-
ciated with lungworm, but it was not possible to assess prevalence 
in this study.
In this population, there was increased likelihood of younger 
and older animals presenting as cases, an age pattern found in 
other populations.28 where increasing immunity to pathological 
challenges, or a build-up of tolerance to other aetiological agents 
occurs as horses reach adulthood. The risk in older animals may 
reflect the development of hypersensitivities and chronic re-
spiratory disease, as seen in ageing populations elsewhere.25,26 
Other risk factors included a cobbled floor (‘flat rocks’) in housing. 
Stabling has been identified as a risk factor for disease through in-
creased exposure to dust and allergens especially in straw or hay, 
but no participants reported using bedding of any sort or feeding 
large quantities of hay. Increased odds could be associated with 
difficulties keeping cobbles clean but may also be a proxy for an-
other management practice not identified, and this warrants fur-
ther investigation.
Horses that were described by owners as performing strenuous 
work were at increased risk of disease in this study. High intensity 
or strenuous exercise can lead to airway contamination and immu-
nocompromise,29 and has been identified as a risk factor for disease 
in other populations.30 Additionally, strenuous exercise in a dusty 
environment can lead to mucosal damage, and dust storms have also 
been associated with increased invasive bacteria in the LRT of hu-
mans.31 Dust exposure during work was not measured during this 
study, but horses commonly worked on dirt roads in dry environ-
mental conditions. It is also possible that respiratory signs may be 
more apparent in animals exercising intensely and therefore, they 
may be more likely to attend clinics as a case.
Stagnant water has not been previously identified as a risk factor 
for equine respiratory disease and a direct causal link cannot be deter-
mined from the current study and it may be a proxy for unmeasured 
variables. However, stagnant water may be contaminated with po-
tentially harmful organisms, such as S. equi, which can survive up to a 
month in drinking water.32
The broad case definition criteria in this unmatched case-con-
trol study could represent a range of aetiologies, potentially 
making the identification of syndrome-specific risk factors more 
challenging. Controls were selected at the regional clinics, hence 
it is also possible that they were not ‘healthy’ and could have been 
suffering from other disease leading to bias. Although respiratory 
disease in working horse populations is recognised as a problem-
atic syndrome,2 there is a lack of published information to com-
pare these results to and they may be specific to this region of 
sub-Saharan Africa.
In conclusion, horses presenting with coughing, nasal dis-
charge and/or dyspnoea at clinics in Ethiopia often do have 
changes in the LRT, in particular neutrophilia and tracheal mucus. 
Colonisation of LRT with S. zooepidemicus was significantly as-
sociated with clinical signs of respiratory disease. The role of S. 
zooepidemicus as a primary cause of respiratory disease should be 
further investigated and interventions to limit exposure are rec-
ommended. Evidence from this study suggests that there is only 
a minor role, if any, played by viral pathogens in this population. 
The only vaccination available and used in this area is against 
African Horse Sickness. Thus, the susceptibility of the population 
to the introduction of a novel viral pathogen should be consid-
ered. Further work is also needed to understand the role of and 
risk factors for equine asthma in this and other working equid 
populations.
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